Tandem Diabetes Care, Inc.
MX ˙ BMV ˙ US8753722037
SecurityMX:TNDM / Tandem Diabetes Care, Inc.
InstitutionQuantinno Capital Management LP
Latest Disclosed Ownership653,870 shares
Latest Disclosed Value $ 12,534,688
Quantinno Capital Management LP reports 123.54% increase in ownership of TNDM / Tandem Diabetes Care, Inc.

On May 15, 2026 - Quantinno Capital Management LP filed a 13F-HR form disclosing ownership of 653,870 shares of Tandem Diabetes Care, Inc. (MX:TNDM) valued at $12,534,688 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 292,509 shares of Tandem Diabetes Care, Inc.. This represents a change in shares of 123.54% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F TANDEM DIABETES CARE COM NEW 875372203 653,870 361,361 123.54 12,535 94.96 0.0209
2026-02-17 2025-12-31 13F TANDEM DIABETES CARE COM NEW 875372203 292,509 91,716 45.68 6,429 163.81 0.0129
2025-11-14 2025-09-30 13F TANDEM DIABETES CARE COM NEW 875372203 200,793 -118,866 -37.19 2,438 -59.10 0.0067
2025-08-14 2025-06-30 13F TANDEM DIABETES CARE COM NEW 875372203 319,659 77,828 32.18 5,958 28.60 0.0257
2025-05-12 2025-03-31 13F TANDEM DIABETES CARE COM NEW 875372203 241,831 190,219 368.56 4,633 149.22 0.0302
2025-02-14 2024-12-31 13F TANDEM DIABETES CARE COM NEW 875372203 51,612 20,467 65.72 1,859 40.83 0.0183
2024-11-14 2024-09-30 13F TANDEM DIABETES CARE COM NEW 875372203 31,145 9,385 43.13 1,321 50.68 0.0172
2024-08-14 2024-06-30 13F TANDEM DIABETES CARE COM NEW 875372203 21,760 9,845 82.63 877 107.58 0.0158
2024-05-14 2024-03-31 13F TANDEM DIABETES CARE COM NEW 875372203 11,915 4,804 67.56 422 100.95 0.0092
2024-02-14 2023-12-31 13F TANDEM DIABETES CARE COM NEW 875372203 7,111 7,111 210 0.0074
2022-05-12 2022-03-31 13F TANDEM DIABETES CARE COM NEW 875372203 0 -2,735 -100.00 0 -100.00
2022-02-14 2021-12-31 13F TANDEM DIABETES CARE COM NEW 875372203 2,735 2,735 412 0.0746
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.